NovoCure Limited (NVCR) ownership: Top institutional holder: FMR LLC ($186.05M). Insider activity: Net Seller (1 buys, 19 sells). 1 recent congressional STOCK Act disclosures. SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| FMR LLC | 17069149.00 | $186.05M | 2026-03-31 |
| BlackRock, Inc. | 13193765.00 | $143.81M | 2026-03-31 |
| VANGUARD GROUP INC | 10958209.00 | $141.69M | 2025-12-31 |
| Soleus Capital Management, L.P. | 10492391.00 | $114.37M | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6251701.00 | $68.14M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4682064.00 | $51.03M | 2026-03-31 |
| MORGAN STANLEY | 4541526.00 | $49.50M | 2026-03-31 |
| WELLS FARGO & COMPANY/MN | 3121237.00 | $34.02M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-02 | |
| Sell | null | 2026-06-02 | |
| Sell | null | 2026-06-02 | |
| Sell | null | 2026-06-02 | |
| Sell | null | 2026-06-02 | |
| Sell | null | 2026-06-02 | |
| Sell | null | 2026-06-02 | |
| Sell | null | 2026-04-28 |
Back to NVCR overview · NVCR earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.